We are live on ! Find out more
PTGX icon

Protagonist Therapeutics
PTGX

34 hedge funds and large institutions have $145M invested in Protagonist Therapeutics in 2016 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$29.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.6M
3
CAM
Cormorant Asset Management
Massachusetts
+$10.9M
4
RCM
RA Capital Management
Massachusetts
+$10.3M
5
BI
BVF Inc
California
+$5.13M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$45M +$29.1M +2,128,719 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$33.4M +$21.6M +1,581,076 New
CAM
3
Cormorant Asset Management
Massachusetts
$16.9M +$10.9M +800,000 New
RCM
4
RA Capital Management
Massachusetts
$15.9M +$10.3M +754,411 New
BI
5
BVF Inc
California
$7.92M +$5.13M +375,000 New
FCMI
6
Foresite Capital Management III
California
$6.29M +$4.73M +346,281 New
BFA
7
BlackRock Fund Advisors
California
$4.36M +$2.82M +206,455 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.01M +$1.95M +142,468 New
DCM
9
DAFNA Capital Management
California
$2.62M +$1.69M +123,804 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.96M +$1.27M +92,820 New
BIT
11
BlackRock Institutional Trust
California
$1.4M +$906K +66,262 New
State Street
12
State Street
Massachusetts
$1.29M +$835K +61,121 New
SIM
13
Spark Investment Management
New York
$889K +$575K +42,100 New
GAMA
14
Graticule Asia Macro Advisors
New York
$673K +$435K +31,827 New
BIM
15
BlackRock Investment Management
Delaware
$611K +$395K +28,898 New
Northern Trust
16
Northern Trust
Illinois
$425K +$275K +20,137 New
CS
17
Credit Suisse
Switzerland
$358K +$231K +16,924 New
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$340K +$220K +16,100 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$301K +$194K +14,202 New
Goldman Sachs
20
Goldman Sachs
New York
$282K +$182K +13,340 New
Jane Street
21
Jane Street
New York
$232K +$150K +10,964 New
TA
22
Teachers Advisors
New York
$170K +$110K +8,037 New
BA
23
BlackRock Advisors
Delaware
$55K +$35.6K +2,605 New
SO
24
STRS Ohio
Ohio
$50K +$32.8K +2,400 New
JP Morgan Chase
25
JP Morgan Chase
New York
$45K +$28.8K +2,108 New
1
2

PTGX Hedge Fund Activity: Q3 2016 in Review

34 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Protagonist Therapeutics (PTGX) for Q3 2016, worth a combined $145M.

Buyers outnumbered sellers: 34 funds opened new PTGX positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $29.1M.

  • 34 institutional investors held Protagonist Therapeutics (PTGX) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $145M of Protagonist Therapeutics stock for Q3 2016.
  • 34 funds opened new Protagonist Therapeutics positions in Q3 2016 and 0 closed out, a net change of +34 holders.
  • The largest Protagonist Therapeutics buyer in Q3 2016 was Fidelity Investments, an estimated $29.1M added.

Based on aggregated 13F filings for Q3 2016.